Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagy.

Aguirre-Hernández C, Maya-Pineda H, Millán JS, Man YKS, Lu YJ, Halldén G.

Oncogenesis. 2018 Jan 24;7(1):6. doi: 10.1038/s41389-017-0020-8.

2.

Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients.

Zhang XF, Yang X, Jia HL, Zhu WW, Lu L, Shi W, Zhang H, Chen JH, Tao YF, Wang ZX, Yang J, Wang LX, Lu M, Zheng Y, Zhao J, Dong QZ, Qin LX.

Cancer Biol Med. 2016 Dec;13(4):459-468. doi: 10.20892/j.issn.2095-3941.2016.0077.

3.

P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth.

Gang X, Yang Y, Zhong J, Jiang K, Pan Y, Karnes RJ, Zhang J, Xu W, Wang G, Huang H.

Oncotarget. 2016 Mar 22;7(12):15135-49. doi: 10.18632/oncotarget.7715.

4.

Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.

Narayanan KB, Ali M, Barclay BJ, Cheng QS, D'Abronzo L, Dornetshuber-Fleiss R, Ghosh PM, Gonzalez Guzman MJ, Lee TJ, Leung PS, Li L, Luanpitpong S, Ratovitski E, Rojanasakul Y, Romano MF, Romano S, Sinha RK, Yedjou C, Al-Mulla F, Al-Temaimi R, Amedei A, Brown DG, Ryan EP, Colacci A, Hamid RA, Mondello C, Raju J, Salem HK, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Kim SY, Bisson WH, Lowe L, Park HH.

Carcinogenesis. 2015 Jun;36 Suppl 1:S89-110. doi: 10.1093/carcin/bgv032. Review.

5.

Oxymatrine downregulates HPV16E7 expression and inhibits cell proliferation in laryngeal squamous cell carcinoma Hep-2 cells in vitro.

Ying XJ, Jin B, Chen XW, Xie J, Xu HM, Dong P.

Biomed Res Int. 2015;2015:150390. doi: 10.1155/2015/150390. Epub 2015 Feb 24.

6.

Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.

Lin HP, Lin CY, Hsiao PH, Wang HD, Jiang SS, Hsu JM, Jim WT, Chen M, Kung HJ, Chuu CP.

PLoS One. 2013 Dec 5;8(12):e82625. doi: 10.1371/journal.pone.0082625. eCollection 2013.

7.

DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells.

Zhao R, Han C, Eisenhauer E, Kroger J, Zhao W, Yu J, Selvendiran K, Liu X, Wani AA, Wang QE.

Mol Cancer Res. 2014 Mar;12(3):370-80. doi: 10.1158/1541-7786.MCR-13-0281. Epub 2013 Nov 18.

8.

Skp2: a novel potential therapeutic target for prostate cancer.

Wang Z, Gao D, Fukushima H, Inuzuka H, Liu P, Wan L, Sarkar FH, Wei W.

Biochim Biophys Acta. 2012 Jan;1825(1):11-7. doi: 10.1016/j.bbcan.2011.09.002. Epub 2011 Sep 22. Review.

9.

Androgens repress expression of the F-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells.

Jiang J, Pan Y, Regan KM, Wu C, Zhang X, Tindall DJ, Huang H.

Prostate. 2012 Feb 1;72(2):225-32. doi: 10.1002/pros.21430. Epub 2011 May 31.

10.

Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.

Bohrer LR, Chen S, Hallstrom TC, Huang H.

Endocrinology. 2010 Nov;151(11):5136-45. doi: 10.1210/en.2010-0436. Epub 2010 Sep 29.

11.

1α,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest.

Washington MN, Kim JS, Weigel NL.

Prostate. 2011 Jan 1;71(1):98-110. doi: 10.1002/pros.21226.

12.

Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP.

Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Chumakov PM, Kravchenko JE, Cohen MB.

Oncogene. 2005 Oct 13;24(45):6773-84.

Supplemental Content

Support Center